ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$101M | −$88M | −$5.0M | −$11M | −$19M | −$7.7M | −$4.8M | −$8.2M | −$17M | −$15M | −$11M | −$9.4M | −$5.3M | −$4.1M | −$7.0M | −$8.3M | — | — | — | — |
| Capital expenditures | $235K | $209K | $0 | $2K | $43K | $19K | $4K | $4K | $3K | $12K | $11K | $19K | $32K | — | $19K | $4K | — | — | — | — |
| Free cash flow | −$101M | −$88M | −$5.0M | −$11M | −$19M | −$7.7M | −$4.8M | −$8.2M | −$17M | −$15M | −$11M | −$9.4M | −$5.3M | — | −$7.0M | −$8.3M | — | — | — | — |
| Stock-based compensation | $29M | $24M | $686K | $556K | $497K | $43K | $151K | $273K | $458K | $576K | $599K | $647K | $283K | $306K | $308K | $458K | $845K | $545K | $50K | $39K |